Effect of Ibuprofen and Acetaminophen in Cardiac Vessels of Childre
Phase 4
Recruiting
- Conditions
- Patent Ductus Arteriosus.Patent ductus arteriosus
- Registration Number
- IRCT20130518013366N10
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Infants less than 28 days old referring to Amir Kabir Hospital with Patent Ductus Arteriosus
Parental consent for participation in the study
No G6PD Enzymatic Deficiency
Exclusion Criteria
Dissatisfaction with using their information in the study
Neonates with congenital heart defects that Patent Ductus Arteriosus were life giving, such as pulmonary artery atresia, congenital or chromosomal major abnormalities, the history of using non-steroidal anti-inflammatory drugs during pregnancy by mother, the presence of Hydrops Fetalis, and a continuous increase in Pulmonary Blood Pressure.
Leaving the hospital with personal consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patent Ductus Arteriosus Closure Status. Timepoint: Before intervention for diagnosis and within three days interval of starting the drug. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method